Akl C Fahed

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Percutaneous Coronary Intervention

Antiplatelet Therapy

Top Venues

Nature communications

Genome medicine

European journal of preventive cardiology

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah M Urbut, So Mi Jemma Cho, Kaavya Paruchuri, Buu Truong, Sara Haidermota, Gina M Peloso, Whitney E Hornsby, Anthony A Philippakis, Akl C Fahed, Pradeep Natarajan
Dynamic Importance of Genomic and Clinical Risk for Coronary Artery Disease Over the Life Course. medRxiv : the preprint server for health sciences (2023)
Injeong Shim, Hiroyuki Kuwahara, Ningning Chen, Mais O Hashem, Lama AlAbdi, Mohamed Abouelhoda, Hong-Hee Won, Pradeep Natarajan, Patrick T Ellinor, Amit V Khera, Xin Gao, Fowzan Sami Alkuraya, Akl C Fahed
Clinical utility of polygenic scores for cardiometabolic disease in Arabs. Nature communications 14 (1) (2023)
Romit Bhattacharya, NingNing Chen, Injeong Shim, Hiroyuki Kuwahara, Xin Gao, Fowzan S Alkuraya, Akl C Fahed
Massive underrepresentation of Arabs in genomic studies of common disease. Genome medicine 15 (1) (2023)
Amanda R Jowell, Romit Bhattacharya, Christopher Marnell, Megan Wong, Sara Haidermota, Mark Trinder, Akl C Fahed, Gina M Peloso, Michael C Honigberg, Pradeep Natarajan
Genetic and Clinical Factors Underlying a Self-Reported Family History of Heart Disease. European journal of preventive cardiology (2023)
Dimitri J Maamari, Farouc A Jaffer, Amit V Khera, Akl C Fahed
CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine? Circulation 145 (10) (2022)
Akl C Fahed, Anthony A Philippakis, Amit V Khera
The potential of polygenic scores to improve cost and efficiency of clinical trials. Nature communications 13 (1) (2022)